TIPIFARNIB IN RELAPSED OR REFRACTORY ANGIOIMMUNOBLASTIC T‐CELL LYMPHOMA (AITL) AND CXCL12+ PERIPHERAL T‐CELL LYMPHOMA (PTCL): PRELIMINARY RESULTS FROM A PHASE 2 STUDY
Hematological Oncology | June 12, 2019 | Volume: 37 | Issue: S2 | Pages: 64-65
10.1002/hon.32_2629